Published in Neuroscience on February 01, 1995
Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc Natl Acad Sci U S A (1996) 1.70
Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer. EMBO J (2006) 1.55
Noncholinergic excitatory actions of motoneurons in the neonatal mammalian spinal cord. Proc Natl Acad Sci U S A (2005) 1.46
Glutamatergic reinnervation through peripheral nerve graft dictates assembly of glutamatergic synapses at rat skeletal muscle. Proc Natl Acad Sci U S A (2005) 1.10
Glutamate receptors localize postsynaptically at neuromuscular junctions in mice. Muscle Nerve (2009) 0.84
Phenotypic characterization of mice heterozygous for a null mutation of glutamate carboxypeptidase II. Synapse (2009) 0.81
Immunohistological and electrophysiological evidence that N-acetylaspartylglutamate is a co-transmitter at the vertebrate neuromuscular junction. Eur J Neurosci (2012) 0.80
Interneuronal synapses formed by motor neurons appear to be glutamatergic. Neuroreport (2011) 0.79
Cyclooxygenase-2, prostaglandin E2 glycerol ester and nitric oxide are involved in muscarine-induced presynaptic enhancement at the vertebrate neuromuscular junction. J Physiol (2013) 0.78
Overdose of D-serine Induces Movement Disorder and Neuromuscular Changes of Zebrafish Larvae. J Toxicol Pathol (2014) 0.77
The expression and function of gelatinolytic activity at the rat neuromuscular junction upon physical exercise. Histochem Cell Biol (2014) 0.76
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges. Am J Bioeth (2009) 6.13
Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science (1982) 5.63
Alzheimer's disease: a disorder of cortical cholinergic innervation. Science (1983) 4.40
Neurology and psychiatry: closing the great divide. Neurology (2000) 3.68
Mucoid Pseudomonas aeruginosa in patients with chronic illnesses. Lancet (1971) 3.23
The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry (2001) 3.20
The glutamatergic basis of human alcoholism. Am J Psychiatry (1995) 3.20
Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol (1981) 3.18
Demographic study of a wild house sparrow population by DNA fingerprinting. Nature (1987) 3.08
Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron (1989) 3.06
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol (1990) 2.66
Inhibition of the receptor-binding function of clathrin adaptor protein AP-2 by dominant-negative mutant mu2 subunit and its effects on endocytosis. EMBO J (1999) 2.60
Oxidative stress in neurodegenerative diseases. Annu Rev Pharmacol Toxicol (1996) 2.56
A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry (1999) 2.44
D-serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry (1998) 2.36
Catecholamine uptake by synaptosomes from rat brain. Structure-activity relationships of drugs with differential effects on dopamine and norepinephrine neurons. Mol Pharmacol (1971) 2.08
Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature (1976) 2.08
Total anomalous pulmonary venous drainage. A clinical and anatomical study of 75 children. Br Heart J (1969) 2.07
Regional differences in H3-norepinephrine and H3-dopamine uptake into rat brain homogenates. J Pharmacol Exp Ther (1969) 1.99
Targeted disruption of serine racemase affects glutamatergic neurotransmission and behavior. Mol Psychiatry (2008) 1.88
Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J (1990) 1.86
Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action. Science (1969) 1.81
Dopaminergic dsyfunction in Tourette syndrome. Ann Neurol (1982) 1.79
Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience (1991) 1.78
Patent ductus arteriosus in infants and children. A review of 936 operations (1946-69). Thorax (1971) 1.73
The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med (1998) 1.72
Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry (1995) 1.71
Modulation of N-methyl-D-aspartate receptor function by glycine transport. Proc Natl Acad Sci U S A (1998) 1.71
Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase. Proc Natl Acad Sci U S A (1996) 1.70
Pilot studies of telemedicine for patients with obsessive-compulsive disorder. Am J Psychiatry (1995) 1.66
Structure and Asn-Pro-Phe binding pocket of the Eps15 homology domain. Science (1998) 1.64
Hydrolysis of the brain dipeptide N-acetyl-L-aspartyl-L-glutamate. Identification and characterization of a novel N-acetylated alpha-linked acidic dipeptidase activity from rat brain. J Biol Chem (1987) 1.64
Incidence of medical complications in spinal cord injury: patients in specialised, compared with non-specialised centres. Paraplegia (1984) 1.61
Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Neurology (2008) 1.57
Catecholamines in fetal and newborn rat brain. J Neurochem (1973) 1.55
Tyrosine hydroxylase in rat brain--cofactor requirements, regional and subcellular distribution. Biochem Pharmacol (1972) 1.49
N-acetylaspartate in neuropsychiatric disorders. Prog Neurobiol (1995) 1.47
Catecholamine uptake by synaptosomes in homogenates of rat brain: stereospecificity in different areas. J Pharmacol Exp Ther (1969) 1.43
Hydroxychloroquine retinopathy. Ophthalmology (2001) 1.42
Goldenhar's syndrome. Arch Ophthalmol (1991) 1.40
The family physician. A comparative study of Minnesota and Wisconsin family physicians practicing in rural and urban communities. Minn Med (1973) 1.40
Neuroleptic malignant syndrome: life-threatening complication of neuroleptic treatment in adolescents with affective disorder. Pediatrics (1991) 1.40
Risk of mortality after spinal cord injury: relationship with social support, education, and income. Spinal Cord (2009) 1.39
Evidence for a cholinergic projection to neocortex from neurons in basal forebrain. Proc Natl Acad Sci U S A (1979) 1.27
Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res (1986) 1.26
Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology. Genes Brain Behav (2010) 1.25
In situ injection of kainic acid: a new method for selectively lesioning neural cell bodies while sparing axons of passage. J Comp Neurol (1978) 1.25
Neurotoxic action of kainic acid. J Neurochem (1983) 1.24
Intramedullary spinal cord metastases: MRI and relevant clinical features from a 13-year institutional case series. AJNR Am J Neuroradiol (2013) 1.22
Specific binding of [3H]kainic acid to receptor sites in rat brain. Mol Pharmacol (1979) 1.21
Histological and neurochemical effects of fetal treatment with methylazoxymethanol on rat neocortex in adulthood. Brain Res (1979) 1.21
Keratoconus and eye rubbing. Am J Ophthalmol (1984) 1.20
The regional vulnerability to hypoglycemia-induced neurotoxicity in organotypic hippocampal culture: protection by early tetrodotoxin or delayed MK-801. J Neurosci (1992) 1.19
Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal. Am J Psychiatry (1998) 1.19
The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs. Am J Psychiatry (1970) 1.18
Trafficking of yellow-fluorescent-protein-tagged mu1 subunit of clathrin adaptor AP-1 complex in living cells. Traffic (2001) 1.18
Psychotropic drug use in very young children. JAMA (2000) 1.15
Cortical degeneration with swollen chromatolytic neurons: its relationship to Pick's disease. J Neuropathol Exp Neurol (1986) 1.15
Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptors. Nature (1982) 1.15
Platelet serotonin, a possible marker for familial autism. J Autism Dev Disord (1991) 1.14
Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am J Psychiatry (1995) 1.13
Association of postoperative delirium with raised serum levels of anticholinergic drugs. Lancet (1981) 1.13
Primary degenerative dementia without Alzheimer pathology. Can J Neurol Sci (1986) 1.13
Glutamate neurotoxicity and the inhibition of protein synthesis in the hippocampal slice. J Neurochem (1991) 1.11
N-acetyl-aspartyl-glutamate: regional levels in rat brain and the effects of brain lesions as determined by a new HPLC method. J Neurochem (1984) 1.10
Topographic analysis of the innervation of the rat neocortex and hippocampus by the basal forebrain cholinergic system. J Comp Neurol (1983) 1.09
Immunocytochemical localization of the N-acetyl-aspartyl-glutamate (NAAG) hydrolyzing enzyme N-acetylated alpha-linked acidic dipeptidase (NAALADase). J Comp Neurol (1992) 1.09
Selective destruction of neurons by a transmitter agonist. Science (1977) 1.08
Avoidance conditioning in different strains of rats: neurochemical correlates. Psychopharmacologia (1973) 1.08
Enhanced NAD(P)H:quinone reductase activity prevents glutamate toxicity produced by oxidative stress. J Neurochem (1991) 1.08
Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J Pharmacol Exp Ther (1989) 1.07
Intracellular modulation of NMDA receptor function by antipsychotic drugs. J Neurosci (2000) 1.07
Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J Comp Neurol (1999) 1.07
Neurochemical aspects of the ontogenesis of cholinergic neurons in the rat brain. Brain Res (1976) 1.06
Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Arch Gen Psychiatry (1980) 1.06
Folylpoly-gamma-glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II. J Biol Chem (1998) 1.06
Neurochemical aspects of the ontogenesis of GABAnergic neurons in the rat brain. Brain Res (1976) 1.05
Down syndrome, Alzheimer's disease and the trisomy 16 mouse. Trends Neurosci (1988) 1.04
The distribution and orientation of noradrenergic fibers in neocortex of the rat: an immunofluorescence study. J Comp Neurol (1978) 1.04
Glutamate and related acidic excitatory neurotransmitters: from basic science to clinical application. FASEB J (1987) 1.04
The neurobiologic consequences of Down syndrome. Brain Res Bull (1986) 1.04
Direct observation of the agonist-specific regional vulnerability to glutamate, NMDA, and kainate neurotoxicity in organotypic hippocampal cultures. Exp Neurol (1991) 1.04
Neocortical cholinergic innervation: a description of extrinsic and intrinsic components in the rat. Exp Brain Res (1981) 1.04
Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum. Nature (1978) 1.03
Ontogenetic development of kainate neurotoxicity: correlates with glutamatergic innervation. Proc Natl Acad Sci U S A (1978) 1.03
N-acetylaspartylglutamate: an endogenous peptide with high affinity for a brain "glutamate" receptor. Proc Natl Acad Sci U S A (1983) 1.03
Alzheimer's disease and Down's syndrome. Ann N Y Acad Sci (1982) 1.01
When should I do dynamic CT myelography? Predicting fast spinal CSF leaks in patients with spontaneous intracranial hypotension. AJNR Am J Neuroradiol (2011) 1.01
Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase). J Pharmacol Exp Ther (1998) 1.01
Home positive-pressure ventilation. Twenty years' experience. Chest (1983) 1.01
Eps15 is constitutively oligomerized due to homophilic interaction of its coiled-coil region. J Biol Chem (1997) 1.01
Paralytic spinal deformity following traumatic spinal-cord injury in children and adolescents. J Bone Joint Surg Am (1981) 1.00
Neuronal localization of specific brain phosphoproteins. Brain Res (1978) 0.99
D-cycloserine added to clozapine for patients with schizophrenia. Am J Psychiatry (1996) 0.99
Heterogeneity of sodium-dependent excitatory amino acid uptake mechanisms in rat brain. J Neurosci Res (1986) 0.99
Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment. Am J Psychiatry (1999) 0.98
Site-directed mutagenesis of predicted active site residues in glutamate carboxypeptidase II. Mol Pharmacol (1999) 0.98
Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients. Am J Psychiatry (1982) 0.98
Ontogenesis of dopaminergic-cholinergic interactions in the rat striatum: a neurochemical study. J Neurochem (1976) 0.98
Clonal structure of the introduced freshwater snail Potamopyrgus antipodarum (Prosobranchia: Hydrobiidae), as revealed by DNA fingerprinting. Proc Biol Sci (1992) 0.97